Cancer Res Treat. 2001 Aug;33(4):286-95. doi: 10.4143/crt.2001.33.4.286.
This study investigates the COX-2 expression in human primary breast carcinomas and its relationship with both angiogenesis and the expression of estrogen receptor.
COX-2 expression, angiogenesis, and estrogen receptor expression were examined by immunohistochemical methods in 167 human breast carcinomas by using monoclonal antibodies against COX-2, CD34, and estrogen receptor protein.
Although COX-2 was expressed in 77.8% of the breast carcinomas (130/167) regardless of histological types, it was not detected at all in benign epithelial cells. Interestingly, COX-2 expression was found to be significantly correlated with tumor angiogenesis (p=0.004), but not with estrogen receptor and other histopathologic parameters.
The results suggest that COX-2 expression occurs frequently in breast tissue during transformation of benign epithelial cells to malignant cells regardless of the estrogen receptor status. COX-2 expression may play a role in tumor angiogenesis that is responsible for tumor growth and metastasis.
本研究调查了 COX-2 在人原发性乳腺癌中的表达及其与血管生成和雌激素受体表达的关系。
采用针对 COX-2、CD34 和雌激素受体蛋白的单克隆抗体,通过免疫组织化学方法检测 167 例人乳腺癌中 COX-2 的表达、血管生成和雌激素受体表达。
尽管 COX-2 在乳腺癌(130/167)中无论组织学类型如何均有表达(77.8%),但在良性上皮细胞中完全未检测到。有趣的是,COX-2 的表达与肿瘤血管生成显著相关(p=0.004),但与雌激素受体和其他组织病理学参数无关。
结果表明,COX-2 的表达在良性上皮细胞向恶性细胞转化过程中经常发生于乳腺组织中,而与雌激素受体状态无关。COX-2 的表达可能在肿瘤血管生成中发挥作用,这是肿瘤生长和转移的原因。